You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sulfacetamide Sodium And Prednisolone Sodium Phosphate patents expire, and what generic alternatives are available?

Sulfacetamide Sodium And Prednisolone Sodium Phosphate is a drug marketed by Bausch And Lomb and Genus and is included in two NDAs.

The generic ingredient in SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE?
  • What are the global sales for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE?
  • What is Average Wholesale Price for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE?
Summary for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
Drug patent expirations by year for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
Pharmacology for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE

US Patents and Regulatory Information for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 074449-001 Dec 29, 1995 RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Genus SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 073630-001 May 27, 1993 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.